Skip to main content
Events
GroupKALSHI

Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?

Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
Vol

$0.00

|
Events

1

|
Markets

1

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

4%
Top Probability
$0.00
Volume
1
Markets
1
Platforms

About This Event

In 2026 If Hantavirus becomes a Public Health Emergency of International Concern in 2026, then the market resolves to Yes. Early close condition: If this event occurs, the market will close the following 10:00 AM ET. If this event occurs, the market will close the following 10:00 AM ET.

Current Market Outlook

Kalshi traders currently price a 4% chance that the World Health Organization declares Hantavirus a Public Health Emergency of International Concern (PHEIC) in 2026. That's roughly a 1-in-25 shot, which the market treats as a remote tail risk rather than a live scenario. For context, the WHO has only declared seven PHEICs since the framework was created in 2005, covering events like H1N1, Ebola, Zika, and COVID-19. A 4% price suggests traders see this as theoretically possible but requiring a dramatic shift in the virus's behavior or spread.

Key Factors Driving the Odds

Hantavirus isn't new. The CDC has tracked cases in the Americas since the 1993 Four Corners outbreak, with about 800 confirmed US cases since then. The disease kills roughly 36% of those infected, which sounds alarming, but transmission requires direct contact with rodent droppings, urine, or saliva. It doesn't spread person-to-person, unlike the airborne pathogens that triggered past PHEICs.

The market likely prices this low because the WHO's PHEIC criteria require an event that's "serious, sudden, unusual, or unexpected" and carries international spread implications. Hantavirus outbreaks are neither sudden nor unusual. They follow predictable seasonal patterns tied to rodent populations. China reported a spike in human cases in early 2025, which briefly pushed the odds higher, but the WHO didn't escalate, and the market settled back down.

Another factor: the WHO has faced criticism for overusing PHEIC declarations, particularly after COVID-19. Director-General Tedros Adhanom Ghebreyesus has signaled a more cautious approach. The bar for a declaration is now higher than it was a decade ago.

What Could Change These Odds

A documented case of human-to-human transmission would be the single biggest catalyst. That happened once in Argentina in 2019 with the Andes virus strain, but it wasn't sustained. If multiple clusters emerged in different countries simultaneously, that would meet the "international spread" test and could push this market toward 20-30%.

A major outbreak in a densely populated urban area, particularly one with weak public health infrastructure, would also raise the odds. The WHO monitors hantavirus through its Global Outbreak Alert and Response Network, so any unusual cluster would trigger rapid assessment.

Watch for the WHO's annual review of epidemic-prone diseases each spring. If hantavirus appears on that list with elevated risk ratings, the market could move before any formal declaration. Otherwise, expect this to stay in the single digits unless something fundamental changes about how the virus spreads.

AI-generated analysis based on market data. Not financial advice.

Overview

Hantavirus is a genus of viruses transmitted primarily by rodents, causing two distinct diseases in humans: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS), also known as hantavirus cardiopulmonary syndrome (HCPS). The World Health Organization (WHO) can declare a Public Health Emergency of International Concern (PHEIC) under the International Health Regulations (IHR) when an event constitutes a public health risk to other states through the international spread of disease and potentially requires a coordinated international response. This prediction market asks whether the WHO will declare hantavirus a PHEIC in 2026, a question that depends on factors such as outbreak severity, geographic spread, human-to-human transmission potential, and the WHO Emergency Committee's assessment. The WHO has declared PHEICs for events like the 2009 H1N1 pandemic, the 2014–2016 Ebola outbreak in West Africa, the 2016 Zika virus epidemic, the 2018–2020 Kivu Ebola outbreak, the 2020 COVID-19 pandemic, and the 2022–2023 mpox outbreak. Hantavirus has historically caused localized outbreaks, such as the 1993 Four Corners outbreak in the United States that identified Sin Nombre virus, and larger HFRS outbreaks in China and Europe. However, no hantavirus outbreak has ever been deemed a PHEIC, partly because human-to-human transmission is rare (documented only for Andes virus in South America) and outbreaks have been geographically contained. Interest in this topic has grown due to recent reports of hantavirus cases in unusual locations or with higher case fatality rates. The WHO's decision to convene an Emergency Committee would require evidence of international spread, unusual disease characteristics, or a significant increase in cases. As of early 2025, no such declaration has been made, and hantavirus remains a neglected tropical disease with limited surveillance in many regions. Researchers and public health officials monitor rodent populations and human cases to assess the risk of a wider outbreak that could trigger a PHEIC. The market's focus on 2026 reflects a specific timeframe for potential escalation. Factors that could influence the outcome include climate change affecting rodent habitats, increased human-rodent contact due to urbanization, and the emergence of new hantavirus strains with higher transmissibility. The WHO's criteria for a PHEIC include seriousness, unexpectedness, international spread, and the need for coordinated action, all of which would need to be met for a declaration.

Historical Context

The WHO's PHEIC mechanism was established by the International Health Regulations (IHR) in 2005, replacing the earlier International Sanitary Regulations. The first PHEIC was declared in 2009 for the H1N1 influenza pandemic. Since then, the WHO has declared seven PHEICs, each triggered by an event with potential for international spread. Hantavirus has never been declared a PHEIC, despite causing significant outbreaks. The 1993 Four Corners outbreak in the southwestern United States killed 12 of 17 confirmed cases (71% case fatality rate) and led to the discovery of Sin Nombre virus. That outbreak was contained through public health measures, including rodent control and public education, without needing international intervention. In Europe, hantavirus causes HFRS, primarily from Puumala virus, with tens of thousands of cases reported annually. The 2010 outbreak in Germany saw over 2,000 cases, the largest in Europe. In Asia, Seoul virus and Hantaan virus cause more severe HFRS, with China reporting 40,000–60,000 cases annually. The 2012 outbreak in Yunnan Province, China, involved over 1,000 cases. Despite these numbers, the WHO has not considered hantavirus a PHEIC because outbreaks remain geographically localized and human-to-human transmission is documented only for Andes virus in Argentina and Chile. The 1996 outbreak in El Bolsón, Argentina, involved person-to-person spread, but it was contained. The WHO's PHEIC criteria require an event to be serious, unusual, and unexpected, with potential for international spread. Hantavirus outbreaks have not met these thresholds due to their rodent-borne nature, which limits human-to-human transmission. However, the emergence of new strains or changes in rodent ecology could alter this assessment. The 2022–2023 mpox PHEIC was declared despite low transmissibility, because of its rapid international spread. A similar pattern for hantavirus would require evidence of sustained human-to-human transmission or a dramatic increase in cases across multiple countries.

Why It Matters

A PHEIC declaration for hantavirus would have significant economic and public health implications. International trade and travel restrictions could follow, as seen during the 2014–2016 Ebola PHEIC, which cost West Africa an estimated $2.2 billion in GDP losses. Countries with endemic hantavirus, such as China, South Korea, and parts of Europe, could face increased surveillance costs, quarantine measures, and disruptions to agriculture. The declaration would also trigger WHO-coordinated response efforts, including vaccine development, rodent control programs, and public health campaigns. For low-income countries with limited healthcare infrastructure, a hantavirus PHEIC could overwhelm local systems, similar to the Ebola crisis in Sierra Leone. Beyond immediate health impacts, a PHEIC would affect global health governance. It would test the WHO's ability to respond to a rodent-borne disease, which differs from the respiratory viruses that have dominated recent PHEICs. The declaration could also influence funding for hantavirus research, which has been underfunded compared to other emerging infectious diseases. The US National Institutes of Health spent about $15 million on hantavirus research in 2023, a fraction of the $5.9 billion for COVID-19. A PHEIC could shift priorities, potentially accelerating development of vaccines and treatments. For the general public, a PHEIC would raise awareness of hantavirus risks, particularly for outdoor workers and rural communities, and could change behavior around rodent exposure.

Was this helpful?
Updated Jul 27, 2026

Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.

Market Insights

Average Yes Price
4¢
Kalshi
Arbitrage Opps
0
Cross-Platform
0

Trade This Market